Calvin Ho to Young Adult
This is a "connection" page, showing publications Calvin Ho has written about Young Adult.
Connection Strength
0.335
-
Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviews. J Patient Rep Outcomes. 2025 Jan 08; 9(1):3.
Score: 0.191
-
Benralizumab versus placebo for hypereosinophilic syndrome: a randomized, placebo-controlled phase 3 trial. Nat Med. 2026 Jun; 32(6):2017-2025.
Score: 0.052
-
Benralizumab does not elicit therapeutic effect in patients?with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial. Br J Dermatol. 2024 Jul 16; 191(2):187-199.
Score: 0.046
-
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis. N Engl J Med. 2024 Jun 27; 390(24):2252-2263.
Score: 0.046